Gregory D. Swiatocha
Examiner (ID: 8654, Phone: (571)272-7022 , Office: P/3725 )
Most Active Art Unit | 3725 |
Art Unit(s) | OPQA, 3799, 3725 |
Total Applications | 399 |
Issued Applications | 243 |
Pending Applications | 3 |
Abandoned Applications | 149 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 6736115
[patent_doc_number] => 20030013750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-16
[patent_title] => 'Isothiazolecarboxamides and their use as microbicides'
[patent_app_type] => new
[patent_app_number] => 09/979856
[patent_app_country] => US
[patent_app_date] => 2001-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12419
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0013/20030013750.pdf
[firstpage_image] =>[orig_patent_app_number] => 09979856
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/979856 | Isothiazolecarboxamides and their use as microbicides | Nov 25, 2001 | Issued |
Array
(
[id] => 5815446
[patent_doc_number] => 20020040149
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-04
[patent_title] => 'EP4 receptor selective agonists in the treatment of osteoporosis'
[patent_app_type] => new
[patent_app_number] => 09/991585
[patent_app_country] => US
[patent_app_date] => 2001-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18494
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20020040149.pdf
[firstpage_image] =>[orig_patent_app_number] => 09991585
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/991585 | EP4 receptor selective agonists in the treatment of osteoporosis | Nov 15, 2001 | Issued |
Array
(
[id] => 1316158
[patent_doc_number] => 06605255
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-08-12
[patent_title] => 'Repinotan kit'
[patent_app_type] => B2
[patent_app_number] => 09/991222
[patent_app_country] => US
[patent_app_date] => 2001-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4506
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/605/06605255.pdf
[firstpage_image] =>[orig_patent_app_number] => 09991222
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/991222 | Repinotan kit | Nov 15, 2001 | Issued |
Array
(
[id] => 6545663
[patent_doc_number] => 20020137740
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-26
[patent_title] => 'Aminothiazole derivatives, process for preparing them and pharmaceutical compositions containing them'
[patent_app_type] => new
[patent_app_number] => 09/998949
[patent_app_country] => US
[patent_app_date] => 2001-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12873
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 4
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20020137740.pdf
[firstpage_image] =>[orig_patent_app_number] => 09998949
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/998949 | Aminothiazole derivatives, process for preparing them and pharmaceutical compositions containing them | Nov 14, 2001 | Abandoned |
Array
(
[id] => 1369713
[patent_doc_number] => 06566384
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-05-20
[patent_title] => 'Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity'
[patent_app_type] => B1
[patent_app_number] => 10/011031
[patent_app_country] => US
[patent_app_date] => 2001-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28738
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 253
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/566/06566384.pdf
[firstpage_image] =>[orig_patent_app_number] => 10011031
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/011031 | Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity | Nov 12, 2001 | Issued |
Array
(
[id] => 6292476
[patent_doc_number] => 20020055640
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-09
[patent_title] => 'Process for the production of dithiazolyl disulfides'
[patent_app_type] => new
[patent_app_number] => 10/011453
[patent_app_country] => US
[patent_app_date] => 2001-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3569
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0055/20020055640.pdf
[firstpage_image] =>[orig_patent_app_number] => 10011453
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/011453 | Process for the production of dithiazolyl disulfides | Nov 5, 2001 | Issued |
Array
(
[id] => 6210245
[patent_doc_number] => 20020072616
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-13
[patent_title] => '3-azabicyclo[3.1.0]hexane derivatives useful in therapy'
[patent_app_type] => new
[patent_app_number] => 10/016745
[patent_app_country] => US
[patent_app_date] => 2001-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 74316
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0072/20020072616.pdf
[firstpage_image] =>[orig_patent_app_number] => 10016745
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/016745 | 3-azabicyclo[3.1.0]hexane derivatives useful in therapy | Oct 29, 2001 | Abandoned |
Array
(
[id] => 1325676
[patent_doc_number] => 06602900
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-08-05
[patent_title] => 'Cyclopentane heptan(ENE)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents'
[patent_app_type] => B2
[patent_app_number] => 10/021485
[patent_app_country] => US
[patent_app_date] => 2001-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11865
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 197
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/602/06602900.pdf
[firstpage_image] =>[orig_patent_app_number] => 10021485
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/021485 | Cyclopentane heptan(ENE)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents | Oct 28, 2001 | Issued |
Array
(
[id] => 1093553
[patent_doc_number] => 06825355
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-11-30
[patent_title] => 'Benzothiazole protein trosine kinase inhibitors'
[patent_app_type] => B2
[patent_app_number] => 10/032609
[patent_app_country] => US
[patent_app_date] => 2001-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24886
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 2909
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/825/06825355.pdf
[firstpage_image] =>[orig_patent_app_number] => 10032609
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/032609 | Benzothiazole protein trosine kinase inhibitors | Oct 25, 2001 | Issued |
Array
(
[id] => 1321086
[patent_doc_number] => RE038188
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2003-07-15
[patent_title] => 'Ethylene derivatives and pesticides containing said derivatives'
[patent_app_type] => E1
[patent_app_number] => 09/983477
[patent_app_country] => US
[patent_app_date] => 2001-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 79601
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 2098
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/RE/038/RE038188.pdf
[firstpage_image] =>[orig_patent_app_number] => 09983477
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/983477 | Ethylene derivatives and pesticides containing said derivatives | Oct 23, 2001 | Issued |
Array
(
[id] => 5788589
[patent_doc_number] => 20020160992
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-31
[patent_title] => 'Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium salts'
[patent_app_type] => new
[patent_app_number] => 10/003514
[patent_app_country] => US
[patent_app_date] => 2001-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7508
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20020160992.pdf
[firstpage_image] =>[orig_patent_app_number] => 10003514
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/003514 | Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium salts | Oct 22, 2001 | Abandoned |
Array
(
[id] => 6658658
[patent_doc_number] => 20030078426
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-24
[patent_title] => 'Amine derivative compounds'
[patent_app_type] => new
[patent_app_number] => 09/971634
[patent_app_country] => US
[patent_app_date] => 2001-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57553
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0078/20030078426.pdf
[firstpage_image] =>[orig_patent_app_number] => 09971634
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/971634 | Amine derivative compounds | Oct 4, 2001 | Issued |
Array
(
[id] => 6529493
[patent_doc_number] => 20020136697
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-26
[patent_title] => '4-hydroxyisothiazole compounds'
[patent_app_type] => new
[patent_app_number] => 09/969738
[patent_app_country] => US
[patent_app_date] => 2001-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5904
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20020136697.pdf
[firstpage_image] =>[orig_patent_app_number] => 09969738
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/969738 | 4-Hydroxyisothiazole compounds | Oct 2, 2001 | Issued |
Array
(
[id] => 6408780
[patent_doc_number] => 20020037915
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-28
[patent_title] => 'Compounds and compositons for treating C1s-mediated diseases and conditions'
[patent_app_type] => new
[patent_app_number] => 09/962304
[patent_app_country] => US
[patent_app_date] => 2001-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 108255
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20020037915.pdf
[firstpage_image] =>[orig_patent_app_number] => 09962304
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/962304 | Compounds and compositions for treating C1s-mediated diseases and conditions | Sep 25, 2001 | Issued |
Array
(
[id] => 5788735
[patent_doc_number] => 20020161019
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-31
[patent_title] => 'Substituted azole derivatives as inhibitors of corticotropin releasing factor'
[patent_app_type] => new
[patent_app_number] => 09/954137
[patent_app_country] => US
[patent_app_date] => 2001-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14644
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0161/20020161019.pdf
[firstpage_image] =>[orig_patent_app_number] => 09954137
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/954137 | Substituted azole derivatives as inhibitors of corticotropin releasing factor | Sep 16, 2001 | Issued |
Array
(
[id] => 1478966
[patent_doc_number] => 06451858
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2002-09-17
[patent_title] => 'Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives'
[patent_app_type] => B2
[patent_app_number] => 09/950957
[patent_app_country] => US
[patent_app_date] => 2001-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13604
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/451/06451858.pdf
[firstpage_image] =>[orig_patent_app_number] => 09950957
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/950957 | Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives | Sep 12, 2001 | Issued |
Array
(
[id] => 6409990
[patent_doc_number] => 20020038034
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-28
[patent_title] => 'Intermediates for the preparation of 2-imidazolin-5-ones'
[patent_app_type] => new
[patent_app_number] => 09/945675
[patent_app_country] => US
[patent_app_date] => 2001-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2526
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20020038034.pdf
[firstpage_image] =>[orig_patent_app_number] => 09945675
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/945675 | Intermediates for the preparation of 2-imidazolin-5-ones | Sep 4, 2001 | Issued |
Array
(
[id] => 1343245
[patent_doc_number] => 06586463
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-07-01
[patent_title] => 'C16 unsaturated FP-selective prostaglandins analogs'
[patent_app_type] => B2
[patent_app_number] => 09/946021
[patent_app_country] => US
[patent_app_date] => 2001-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8320
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 160
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/586/06586463.pdf
[firstpage_image] =>[orig_patent_app_number] => 09946021
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/946021 | C16 unsaturated FP-selective prostaglandins analogs | Sep 3, 2001 | Issued |
Array
(
[id] => 6624558
[patent_doc_number] => 20020016327
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-07
[patent_title] => 'Compounds and methods of use for treatment of neurogenic inflammation'
[patent_app_type] => new
[patent_app_number] => 09/944881
[patent_app_country] => US
[patent_app_date] => 2001-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5488
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0016/20020016327.pdf
[firstpage_image] =>[orig_patent_app_number] => 09944881
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/944881 | Compounds and methods of use for treatment of neurogenic inflammation | Aug 30, 2001 | Issued |
Array
(
[id] => 1478975
[patent_doc_number] => 06451859
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-17
[patent_title] => 'C16 unsaturated FP-selective prostaglandins analogs'
[patent_app_type] => B1
[patent_app_number] => 09/914531
[patent_app_country] => US
[patent_app_date] => 2001-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10889
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/451/06451859.pdf
[firstpage_image] =>[orig_patent_app_number] => 09914531
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/914531 | C16 unsaturated FP-selective prostaglandins analogs | Aug 28, 2001 | Issued |